The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis

…, SZ Aydin, M Boers, H Direskeneli, K Herlyn… - The Journal of …, 2011 - jrheum.org
There has been a marked increase in the past 15 years in the number and quality of clinical
trials in the idiopathic inflammatory vasculitides, especially the small-vessel vasculitides …

Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda

…, TA Kermani, EL Matteson, M Boers, K Herlyn… - The Journal of …, 2011 - jrheum.org
Giant cell (GCA) and Takayasu’s arteritis (TAK) are 2 forms of large-vessel vasculitis (LVV)
that involve the aorta and its major branches. GCA has a predilection for the cranial branches, …

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

PA Merkel, K Herlyn, RW Martin… - Arthritis & …, 2002 - Wiley Online Library
Objective To document disease activity and functional status in patients with scleroderma (systemic
sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to …

Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register

E Reinhold‐Keller, K Herlyn… - Arthritis Care & …, 2005 - Wiley Online Library
Objective To register all newly diagnosed patients with primary systemic vasculitides (PSV)
in a large region in northern Germany. Methods Between January 1, 1998 and December 31, …

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

JU Holle, C Dubrau, K Herlyn, M Heller… - Annals of the …, 2012 - ard.bmj.com
Objective First, to investigate the overall efficacy and safety of rituximab (RTX) in refractory
granulomatosis with polyangiitis (GPA) in a tertiary referral centre. Second, to compare the …

Development and validation of a disease extent index for Wegener's granulomatosis.

K De Groot, WL Gross, K Herlyn… - Clinical …, 2001 - europepmc.org
Aims The quantitative assessment of disease extent (staging) and activity (grading) in patients
with ANCA-associated vasculitides is one prerequisite for the comparison of outcomes in …

B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions

…, P Lamprecht, K Herlyn, K Holl-Ulrich… - Annals of the …, 2006 - ard.bmj.com
K Herlyn1, … K Holl-Ulrich2, … Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A,
Rajewsky K, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev…

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

K Herlyn, F Buckert, WL Gross… - Rheumatology, 2014 - academic.oup.com
Objectives. The aim of this study was to investigate the period prevalences of ANCA-associated
vasculitides (AAV), including granulomatosis with polyangiitis (GPA), microscopic …

Patient‐reported outcome assessment in vasculitis may provide important data and a unique perspective

K Herlyn, B Hellmich, P Seo… - Arthritis care & research, 2010 - Wiley Online Library
… E-mail: karen.herlyn@uk-sh.de. Submitted for publication January 8, 2010; accepted in …
De Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease …

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexate

…, K Herlyn, WL Gross, K De Groot - Arthritis Care & …, 2002 - Wiley Online Library
Objective To examine the long‐term efficacy of low‐dose intravenous methotrexate (MTX)
with and without concomitant glucocorticoids (GC) for remission maintenance in patients with …